Curcumin alone and in combination with augmentin protects against pulmonaryinflammation and acute lung injury generated during Klebsiella pneumoniae B5055-induced lung infection in BALB/c mice
Authors:
- 1 April 2010
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 59 (4) , 429-437
Abstract
Acute lung injuries due to acute lung infections remain a major cause ofmortality. Thus a combination of an antibiotic and a compound with immunomodulatoryand anti-inflammatory activities can help to overcome acute lung infection-inducedinjuries. Curcumin derived from the rhizome of turmeric has been used fordecades and it exhibits anti-inflammatory, anti-carcinogenic, immunomodulatoryproperties by downregulation of various inflammatory mediators. Keeping theseproperties in mind, we investigated the anti-inflammatory properties of curcuminin a mouse model of acute inflammation by introducingKlebsiella pneumoniaeB5055 into BALB/c mice via the intranasal route. Intranasal instillationof bacteria in this mouse model of acute pneumonia-induced inflammation resultedin a significant increase in neutrophil infiltration in the lungs along withincreased production of various inflammatory mediators [i.e. malondialdehyde (MDA),myeloperoxidase (MPO), nitric oxide (NO), tumour necrosisfactor (TNF)-α] in the lung tissue. The animalsthat received curcumin alone orally or in combination with augmentin, 15 daysprior to bacterial instillation into the lungs via the intranasal route, showeda significant (PP0.05) as compared tothe control group. We therefore conclude that curcumin ameliorates lung inflammationinduced byK. pneumoniaeB5055 without significantly (P<0.05) decreasing the bacterial load in the lung tissue whereasaugmentin takes care of bacterial proliferation. Hence, curcumin can be usedas an adjunct therapy along with antibiotics as an anti-inflammatory or animmunomodulatory agent in the case of acute lung infection.Keywords
This publication has 40 references indexed in Scilit:
- Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical TrialsAntioxidants & Redox Signaling, 2008
- Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodentsClinical and Experimental Immunology, 2006
- Curcumin: The story so farEuropean Journal of Cancer, 2005
- Adherence to, Invasion by, and Cytokine Production in Response to Serotype VIII Group B StreptococciInfection and Immunity, 2004
- Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid‐induced colitisBritish Journal of Pharmacology, 2003
- Macrolides as Immunomodulatory AgentsCurrent Medicinal Chemistry -Anti- Inflammatory & Anti-Allergy Agents, 2002
- Role of oral antibiotics in treatment of community-acquired lower respiratory tract infectionsDiagnostic Microbiology and Infectious Disease, 1997
- Curcumin, an Anti-tumor Promoter and Anti-inflammatory Agent, Inhibits Induction of Nitric Oxide Synthase in Activated MacrophagesBiochemical and Biophysical Research Communications, 1995
- Pulmonary O2Toxicity: Role of Endogenous Tumor Necrosis FactorExperimental Lung Research, 1995
- Pharmacology ofCurcuma longaPlanta Medica, 1991